Investors

Date	Name	Title	Type	Shares Traded	Price Range
Apr 27, 2012	van plew daniel p	Officer	Disposition (Non Open Market)	15,990	138.36
Apr 27, 2012	van plew daniel p	Officer	Option Execute	35,216	20.90
Apr 19, 2012	baker charles a	Director	Automatic Sell	12,910	125.00
Apr 19, 2012	baker charles a	Director	Option Execute	12,910	18.80
Apr 17, 2012	baker charles a	Director	Automatic Sell	2,090	125.00
Apr 17, 2012	baker charles a	Director	Option Execute	2,090	18.80
Mar 30, 2012	vagelos p roy	Officer	Disposition (Non Open Market)	1,852	n/a
Mar 26, 2012	goldstein joseph l	Director	Automatic Sell	5,000	120.00
Mar 26, 2012	goldstein joseph l	Director	Option Execute	5,000	18.61
Mar 26, 2012	yancopoulos george	Officer	Automatic Sell	33,150	120.21 - 121.09
Mar 15, 2012	goldstein joseph l	Director	Automatic Sell	10,000	110.77 - 115.00
Mar 15, 2012	goldstein joseph l	Director	Option Execute	10,000	18.61
Mar 1, 2012	brown michael s	Director	Automatic Sell	20,000	102.65 - 104.32
Mar 1, 2012	brown michael s	Director	Option Execute	20,000	15.80 - 19.69
Feb 23, 2012	shooter eric m	Director	Acquisition (Non Open Market)	20,000	n/a
Feb 23, 2012	shooter eric m	Director	Sell	20,000	103.51 - 104.05
Feb 22, 2012	powchik peter	Officer	Automatic Sell	49,254	94.71 - 98.05
Feb 21, 2012	powchik peter	Officer	Automatic Sell	60,612	100.32
Feb 21, 2012	powchik peter	Officer	Option Execute	109,866	15.64 - 21.92
Feb 16, 2012	mccorkle douglas s	Officer	Sell	5,353	107.50
Showing 201-220 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.